✦ LIBER ✦

Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastoma

✍ Scribed by Lou, Emil; Peters, Katherine B.; Sumrall, Ashley L.; Desjardins, Annick; Reardon, David A.; Lipp, Eric S.; Herndon, James E.; Coan, April; Bailey, Leighann; Turner, Scott; Friedman, Henry S.; Vredenburgh, James J.

Book ID: 125466660
Publisher: Wiley (John Wiley & Sons)
Year: 2013
Tongue: English
Weight: 488 KB
Volume: 2
Category: Article
ISSN: 2045-7634
DOI: 10.1002/cam4.58

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Feasibility Trial of Concurrent Radiat

A Feasibility Trial of Concurrent Radiation, Temozolomide, and Bevacizumab Followed by Temozolomide and Bevacizumab for Resectable and Unresectable Glioblastoma Multiforme of the Brain

✍ R.H. Liebross; R. Birhiray; S. Schultz; T. Payner; N. Gupta; R. Young; A. Cohen- 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB

AVAglio: Phase 3 trial of bevacizumab pl

AVAglio: Phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiforme

✍ O. L. Chinot; T. de La Motte Rouge; N. Moore; A. Zeaiter; A. Das; H. Phillips; Z 📂 Article 📅 2011 🏛 Springer Healthcare Communications 🌐 English ⚖ 625 KB

A phase II trial of temozolomide in pati

A phase II trial of temozolomide in patients with unresectable or metastatic soft tissue sarcoma

✍ Susan M. Talbot; Mary Louise Keohan; Mary Hesdorffer; Russell Orrico; Emilia Bag 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 3 views

## Abstract ## BACKGROUND The objective of this study was to assess the efficacy and toxicity of the imidazotetrazine derivative temozolomide for patients with unresectable or metastatic soft tissue sarcoma. ## METHODS Twenty‐five of 26 patients were eligible and assessable for toxicity and resp

Phase II Study of Bevacizumab (BEV), Tem

Phase II Study of Bevacizumab (BEV), Temozolomide (TMZ) and Hypofractionated Stereotactic Radiotherapy (HFSRT) for Newly Diagnosed Glioblastoma (GBM)

✍ K. Beal; A. Omuro; S. Karimi; D. Correa; T.A. Chan; L.M. DeAngelis; Y. Yamada; L 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Phase II study of carboplatin, irinoteca

Phase II study of carboplatin, irinotecan, and bevacizumab for bevacizumab naïve, recurrent glioblastoma

✍ David A. Reardon; Annick Desjardins; Katherine B. Peters; Sridharan Gururangan; 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 736 KB

Phase II Trial of Hypofractionated IMRT

Phase II Trial of Hypofractionated IMRT With Temozolomide for Patients With Newly Diagnosed Glioblastoma Multiforme

✍ Krishna Reddy; Denise Damek; Laurie E. Gaspar; Douglas Ney; Allen Waziri; Kevin 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 165 KB